These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080 [TBL] [Abstract][Full Text] [Related]
10. Antithrombotic agents in coronary artery disease. Cairns JA; Hirsh J; Lewis HD; Resnekov L; Théroux P Chest; 1992 Oct; 102(4 Suppl):456S-481S. PubMed ID: 1395829 [No Abstract] [Full Text] [Related]
11. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease. Thompson PL; Verheugt FW Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549 [TBL] [Abstract][Full Text] [Related]
12. New antithrombotic agents for the treatment of coronary artery disease: overview. Schneider DJ Coron Artery Dis; 2012 Sep; 23(6):367. PubMed ID: 22850479 [No Abstract] [Full Text] [Related]
13. Antithrombotics in atrial fibrillation and coronary disease. Velagapudi P; Turagam MK; Agrawal H; Mittal M; Kocheril AG; Aggarwal K Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):977-86. PubMed ID: 25046150 [TBL] [Abstract][Full Text] [Related]
14. Almanac 2013: stable coronary artery disease. Islam S; Timmis A Wien Klin Wochenschr; 2013 Dec; 125(23-24):776-83. PubMed ID: 24297269 [No Abstract] [Full Text] [Related]
15. Antithrombotic therapy in acute coronary syndromes. Sabatine MS; Jang IK Acta Cardiol; 1999 Feb; 54(1):3-29. PubMed ID: 10214473 [No Abstract] [Full Text] [Related]
16. [Oral anticoagulants in elderly patients with coronary artery disease and atrial fibrillation]. Gallet R; Teiger E Ann Cardiol Angeiol (Paris); 2018 Dec; 67(6):404-410. PubMed ID: 30342831 [TBL] [Abstract][Full Text] [Related]
17. Trials of antithrombotic therapy in percutaneous coronary intervention: what evidence do we need to optimise our practice? Cuisset T; Capodanno D EuroIntervention; 2018 May; 14(1):19-23. PubMed ID: 29786540 [No Abstract] [Full Text] [Related]
18. Endeavours to define optimal antithrombotic therapy after percutaneous coronary intervention. Kimura T EuroIntervention; 2017 Dec; 13(12):e1386-e1391. PubMed ID: 29208578 [No Abstract] [Full Text] [Related]
19. Impact of race and gender on antithrombotic therapy. Capodanno D; Angiolillo DJ Thromb Haemost; 2010 Sep; 104(3):471-84. PubMed ID: 20664898 [TBL] [Abstract][Full Text] [Related]